This study is looking at whether cognitive behavioural therapy can help people with Bipolar. Participants receive a study treatment and complete follow-up visits and assessments.

In United States

BipolarityDeviceFrom 18 Years to 64 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: Bipolarity

View study

CompletedNCT04597450

Lu AG06466 in people with PTSD (PTSD)

This study is completed in the United States. It focuses on PTSD.

In United States

PTSDDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: H. Lundbeck A/S
Condition: PTSD

View study

CompletedNCT04959032

Lumateperone for the Prevention of Relapse in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 60 Years

Countries: United States, Bulgaria, Poland, ...
Sponsor: Intra-Cellular Therapies, Inc.
Condition: Schizophrenia

View study

CompletedNCT03249376

Lumateperone Monotherapy for Depression in bipolarity Conducted Globally

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Bipolarity, DepressionDrugFrom 18 Years to 75 Years

Countries: United States, Bulgaria, Colombia, ...
Sponsor: Intra-Cellular Therapies, Inc.
Condition: Bipolarity, Depression

View study

CompletedNCT02392182

Lung HIV Microbiome Project (Michigan Site)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionObservationalFrom 18 Years to 80 Years

Countries: United States
Sponsor: University of Michigan
Condition: Addiction

View study

CompletedNCT00868959

Lurasidone - A 24-week Extension Study of people with Bipolar I Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Bipolarity, DepressionDrugFrom 18 Years to 75 Years

Countries: United States, France, Canada, ...
Sponsor: Sumitomo Pharma America, Inc.
Condition: Bipolarity, Depression

View study

CompletedNCT00868452

Lurasidone - A 6-week Study of people with Bipolar I Depression (Add-on)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Bipolarity, DepressionDrugFrom 18 Years to 75 Years

Countries: United States, France, Czechia, ...
Sponsor: Sumitomo Pharma America, Inc.
Condition: Bipolarity, Depression

View study

CompletedNCT00868699

Lurasidone - A 6-week Study of people with Bipolar I Depression (Monotherapy)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Bipolarity, DepressionDrugFrom 18 Years to 75 Years

Countries: United States, France, Czechia, ...
Sponsor: Sumitomo Pharma America, Inc.
Condition: Bipolarity, Depression

View study

CompletedNCT02199743

Lurasidone Effects on Tissue Glutamate in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: University of Texas Southwestern Medical Center
Condition: Schizophrenia

View study

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.